Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

All items in the Healthy Skepticism Library

All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.

Page 205 of 206 pages ‹ First  < 203 204 205 206 > 

Bergus GR, Chapman GB, Gjerde C, Elstein AS.
Clinical reasoning about new symptoms despite preexisting disease: sources of error and order effects.
Fam Med 1995;27:(5):314-20

Beerworth EE, Tiller JW.
Liability in prescribing choice: the example of the antidepressants.
Aust N Z J Psychiatry 1998;32:(4):560-6

Barry HC, Ebell MH, Shaughnessy AF, Slawson DC, Nietzke F.
Family physicians' use of medical abstracts to guide decision making: style or substance?
J Am Board Fam Pract 2001;14:(6):437-42

Axsom D, Yates S, Chaiken S.
Audience response as a heuristic cue in persuasion.
J Pers Soc Psychol 1987;53:(1):30-40

Avorn J, Solomon DH.
Cultural and economic factors that (mis)shape antibiotic use: the nonpharmacologic basis of therapeutics.
Ann Intern Med 2000 18;133:(2):128-35

Avorn J, Soumerai SB
Improving drug-therapy decisions through educational outreach. A randomized controlled trial of academically based 'detailing'.
NEJM 1983 16;308:(24):1457

Astrup A, Marckmann P, Blundell J.
Oiling of health messages in marketing of food.
Lancet 2000 25;356:(9244):1786

Arkes HR.
Impediments to accurate clinical judgment and possible ways to minimize their impact.
J Consult Clin Psychol 1981;49:(3):323-30

Quality standards for health information on the Internet
SIM Quarterly 1997 Dec

Levin AA
HealthFacts 1994 Oct

[No authors listed].
European drug regulation--anti-protectionism or consumer protection?
Lancet 1991 29;337:(8757):1571-2

Phillips & Cohen
Whistleblower ('qui tam') lawsuit against Glaxo
Glaxo Whistleblower Case: Off-label marketing and kickbacks settlement 2012

Phillips & Cohen
Glaxo’s settlement agreement and the government’s charges against Glaxo
Glaxo Whistleblower Case: Off-label marketing and kickbacks settlement 2012

Harvey K
Pfizer Includes Foreign Corrupt Practices Act Violations in Its Arsenal of Illegal Activities
Worst Pills, Best Pills 2012 Sep

Gupta S, Fugh-Berman A, Scialli AR
Ethics and Eplerenone
J Med Ethics;

Buetow S.
What motivates health professionals? Opportunities to gain greater insight from theory.
J Health Serv Res Policy 2007;12:(3):183-5

Dickinson HD.
Evidence-based decision-making: an argumentative approach.
Int J Med Inform 1998;51:(2-3):71-81

Eva KW, Regehr G.
Knowing when to look it up: a new conception of self-assessment ability.
Acad Med 2007;82:(10):

Rudick DH.
The ungifted physician.
JAMA 1998 23-30;280:(12):1052

Malcolm L, Wright L, Seers M, Davies L, Guthrie J.
Laboratory expenditure in Pegasus Medical Group: a comparison of high and low users of laboratory tests with academics.
N Z Med J 2000 10;113:(1105):79-81

'One pill makes you larger...' Don't be seduced by pharmaceutical companies.
Am J Nurs. 2000;100:(12):7

Ottati VC, Isbell LM.
Effects of mood during exposure to target information on subsequently reported judgments: an on-line model of misattribution and correction.
J Pers Soc Psychol 1996;71:(1):39-53

O'Toole TP, Kathuria N, Mishra M, Schukart D.
Teaching professionalism within a community context: perspectives from a national demonstration project.
Acad Med 2005 Apr;80:(4):339-43

Naylor CD.
The complex world of prescribing behavior.
JAMA 2004 7;291:(1):104-6

Nathan DG, Weatherall DJ.
Academic freedom in clinical research.
N Engl J Med 2002 24;347:(17):1368-71

Mukamal KJ, Markson LJ, Flier SR, Calabrese D.
Restocking the sample closet: results of a trial to alter medication prescribing.
J Am Board Fam Pract 2002;15:(4):285-9

Morgan PP.
Are physicians learning from what they read in journals?
Can Med Assoc J 1985 15;133:(4):263

Montori VM, Jaeschke R, Schünemann HJ, Bhandari M, Brozek JL, Devereaux PJ, Guyatt GH.
Users' guide to detecting misleading claims in clinical research reports.
BMJ 2004 6;329:(7474):1093-6

Miller NM, McGowen RK.
The painful truth: physicians are not invincible.
South Med J 2000;93:(10):966-73

Menkes DB.
Exporting hazards to developing countries.
World Health Forum 1998;19:(4):412-6

Boldrin M, Levine DK
The Case Against Patents
Federal Reserve Bank of St Louis 2012

Lilford RJ, Pauker SG, Braunholtz DA, Chard J.
Decision analysis and the implementation of research findings.
BMJ 1998 8;317:(7155):405-9

Lexchin J.
Inappropriate prescribing: how much are patients at fault?
Can Fam Physician 1996;42:1903-4:

Lempp H, Seale C.
The hidden curriculum in undergraduate medical education: qualitative study of medical students' perceptions of teaching.
BMJ 2004 2;329:(7469):770-3

Laing R, Hogerzeil H, Ross-Degnan D.
Ten recommendations to improve use of medicines in developing countries.
Health Policy Plan 2001;16:(1):13-20

Kunin CM, Lipton HL, Tupasi T, Sacks T, Scheckler WE, Jivani A, Goic A, Martin RR, Guerrant RL, Thamlikitkul V.
Social, behavioral, and practical factors affecting antibiotic use worldwide: report of Task Force 4.
Rev Infect Dis 1987;9:

Kruglanski AW, Webster DM, Klem A.
Motivated resistance and openness to persuasion in the presence or absence of prior information.
J Pers Soc Psychol 1993;65:(5):861-76

Klein D, MacDonald A, Drummond N, Cave A.
A qualitative study to identify factors influencing COXIB prescribed by family physicians for musculoskeletal disorders.
Fam Pract 2006;23:(6):659-65

Kieburtz KD, Johnson RE.
Prescribing rate of internists in an HMO and the influence of information sources.
GHAA J 1986;7:(1):60-71

Kerr NL, Tindale RS.
Group performance and decision making.
Annu Rev Psychol 2004;55:623-55:

Kessenich CR.
The garden of good and evil: pharmaceutical companies and the perspective practices of PNPs.
J Pediatr Health Care 2000;14:(6):324-6

Kee F, Bickle I.
Critical thinking and critical appraisal: the chicken and the egg?
QJM 2004;97:(9):609-14

Kassirer JP.
A piece of my mind: financial indigestion.
JAMA 2000 1;284:(17):2156-7

Hubbard T, Love J.
A new trade framework for global healthcare R&D.
PLoS Biol 2004;2:(2):E52

Hausman CL, Weiss JC, Lawrence JS, Zeleznik C.
Confidence weighted answer technique in a group of pediatric residents.
Med Teach 1990;12:(2):163-8

Hammond JS, Keeney RL, Raiffa H.
The hidden traps in decision making.
Clin Lab Manage Rev 1999;13:(1):39-47

Epstein S.
Integration of the cognitive and the psychodynamic unconscious.
Am Psychol 1994;49:(8):709-24

Gruppen LD, Margolin J, Wisdom K, Grum CM.
Outcome bias and cognitive dissonance in evaluating treatment decisions.
Acad Med 1994;69:(10):

Gruppen LD, Wolf FM, Van Voorhees C, Stross JK.
The influence of prior experience and confidence on physician preferences for information sources and continuity of care.
Res Med Educ 1986;25:177-82:

Gaither CA, Bagozzi RP, Ascione FJ, Kirking DM.
The determinants of physician attitudes and subjective norms toward drug information sources: modification and test of the theory of reasoned action.
Pharm Res 1997;14:(10):1298-308

Fuhrer MJ, Grabois M.
Information sources that influence physiatrists' adoption of new clinical practices.
Arch Phys Med Rehabil 1988;69:(3):

Friedman C, Gatti G, Elstein A, Franz T, Murphy G, Wolf F
Are clinicians correct when they believe they are correct? Implications for medical decision support.
Stud Health Technol Inform 2001;84:(Pt 1):454-8.

Friedler E.
The evolving doctor-patient to provider-consumer relationship.
J Fam Pract 1997;45:(6):485

Friedlander ML, Stockman SJ.
Anchoring and publicity effects in clinical judgment.
J Clin Psychol 1983;39:(4):637-43

Freemantle N
Are decisions taken by health care professionals rational? A non systematic review of experimental and quasi experimental literature.
Health Policy 1996;38:(2):71-81

Freemantle N, Bloor K
Lessons from international experience in controlling pharmaceutical expenditure. I: Influencing patients.
BMJ 1996 8;312:(7044):1469-71

Forrow L, Taylor WC, Arnold RM.
Absolutely relative: how research results are summarized can affect treatment decisions.
Am J Med 1992;92:(2):121-4

Fischhoff B, Bostrom A, Quadrel MJ.
Risk perception and communication.
Annu Rev Public Health 1993;14:183-203:

Feinstein AR.
'Clinical Judgment' revisited: the distraction of quantitative models.
Ann Intern Med 1994 1;120:(9):799-805

Elstein AS, Schwartz A.
Clinical problem solving and diagnostic decision making: selective review of the cognitive literature.
BMJ 2002 23;324:(7339):729-32

Elstein AS, Holmes MM, Ravitch MM, Rovner DR, Holzman GB, Rothert ML.
Medical decisions in perspective: applied research in cognitive psychology.
Perspect Biol Med 1983;26:(3):486-501

Edwards W, Fasolo B.
Decision technology.
Annu Rev Psychol 2001;52:581-606:

Ebell MH, Barry HC, Slawson DC, Shaughnessy AF.
Finding POEMs in the medical literature.
J Fam Pract 1999;48:(5):350-5

Doust J, Del Mar C.
Why do doctors use treatments that do not work? For many reasons - including their inability to stand idle and do nothing
BMJ 2004 28;328:(7438):474-5

Dowie J.
The research-practice gap and the role of decision analysis in closing it.
Health Care Anal 1996;4:(1):5-18

DiMasi JA, Hansen RW, Grabowski HG.
The price of innovation: new estimates of drug development costs.
J Health Econ 2003;22:(2):151-85

Deyo RA.
Gaps, tensions, and conflicts in the FDA approval process: implications for clinical practice.
J Am Board Fam Pract 2004;17:(2):142-9

Janis IL, Kaye D, Kirschner P.
Facilitating effects of 'EATING-WHILE-READING' on Responsiveness to Persuasive Communications.
J Pers Soc Psychol 1965;95:181-6:

Yavas U, Riecken G.
A comparison of medical professionals with favorable and unfavorable attitudes toward advertising: an empirical study.
Health Mark Q 2001;18:(3-4):13-26

Wood W.
Attitude change: persuasion and social influence.
Annu Rev Psychol 2000;51:539-70:

Wilkes MS, Hoffman JR.
An innovative approach to educating medical students about pharmaceutical promotion.
Acad Med 2001;76:(12):1271-7;jsessionid=Q2pST3nqdh1K2KKqfnJssTZPgGsTh55TXJkCm2K1TkhgfZLr0hLd!755119086!181195629!8091!-1?issn=1040-2446&volume=76&issue=12&spage=1271

Prosser H, Walley T.
New drug prescribing by hospital doctors: the nature and meaning of knowledge.
Soc Sci Med 2006;62:(7):1565-78

Shiell A, Chapman S.
The inertia of self-regulation: a game-theoretic approach to reducing passive smoking in restaurants.
Soc Sci Med 2000;51:(7):1111-9

Rucker TD, Schiff G.
Drug formularies: myths-in-formation.
Med Care 1990;28:(10):928-42

Denig P, Haaijer-Ruskamp FM, Wesseling H, Versluis A.
Drug expectations and drug choices of hospital physicians.
J Intern Med 1993;234:(2):155-63

Davidoff F.
Evangelists and snails redux: the case of cholesterol screening.
Ann Intern Med 1996 1;124:(5):513-4

Davidoff F.
Patient management problems: heuristics and biases.
Med Decis Making 1988;8:(2):87-9

Cutts C, Tett SE.
Doctors perceptions of the influences on their prescribing: a comparison of general practitioners based in rural and urban Australia.
Eur J Clin Pharmacol 2003;58:(11):761-6

Curtis LH, Østbye T, Sendersky V, Hutchison S, Dans PE, Wright A, Woosley RL, Schulman KA.
Inappropriate prescribing for elderly Americans in a large outpatient population.
Arch Intern Med 2004 9-23;164:(15):1621-5

Cohen SJ, Weinberger M, Mazzuca SA, McDonald CJ.
Perceived influence of different information sources on the decision-making of internal medicine house staff and faculty.
Soc Sci Med 1982;16:(14):1361-4

Cialdella P, Figon G, Haugh MC, Boissel JP.
Prescription intentions in relation to therapeutic information: a study of 117 French general practitioners.
Soc Sci Med 1991;33:(11):1263-74

Christensen C, Heckerling PS, Mackesy ME, Bernstein LM, Elstein AS.
Framing bias among expert and novice physicians.
Acad Med 1991;66:(9):;jsessionid=Q6QGdL88GGQNwN2c2Vndg7MfmnlGJxCHrHhZGHD2gJ6rdQGsJj1Q!755119086!181195629!8091!-1?issn=1040-2446&volume=66&issue=9&spage=S76

Chinburapa V, Larson LN, Brucks M, Draugalis J, Bootman JL, Puto CP.
Physician prescribing decisions: the effects of situational involvement and task complexity on information acquisition and decision making.
Soc Sci Med 1993;36:(11):1473-82

Calvo CB, Rubinstein A.
Influence of new evidence on prescription patterns.
J Am Board Fam Pract 2002;15:(6):457-62

Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PA, Rubin HR
Why don't physicians follow clinical practice guidelines? A framework for improvement.
JAMA 1999 20;282:(15):1458

Britten N, Jenkins L, Barber N, Bradley C, Stevenson F.
Developing a measure for the appropriateness of prescribing in general practice.
Qual Saf Health Care 2003;12:(4):246-50

Bobbio M, Demichelis B, Giustetto G.
Completeness of reporting trial results: effect on physicians' willingness to prescribe.
Lancet 1994 14;343:(8907):1209-11

Pippalla RS, Riley DA, Chinburapa V.
Influencing the prescribing behaviour of physicians: a metaevaluation.
J Clin Pharm Ther 1995;20:(4):189-98

Prochaska JO, Velicer WF.
The transtheoretical model of health behavior change.
Am J Health Promot 1997;12:(1):38-48

Rafferty T, Wilson-Davis K, McGavock H
How has fundholding in Northern Ireland affected prescribing patterns? A longitudinal study.
BMJ 1997 19;315:166-170

Raisch DW
A model of methods for influencing prescribing: Part II. A review of educational methods, theories of human inference, and delineation of the model.
DICP 1990;24:(5):537-42

Raisch DW, Troutman WG, Sather MR, Fudala PJ.
Variability in the assessment of adverse events in a multicenter clinical trial.
Clin Ther 2001;23:(12):2011-20

Ray WA, Stein CM.
Reform of drug regulation--beyond an independent drug-safety board.
N Engl J Med 2006 12;354:(2):194-201

Fugh-Berman A, Scialli AR.
Gynecologists and estrogen: an affair of the heart.
Perspect Biol Med 2006;49:(1):115-30

Robertson J, Fryer JL, O'Connell DL, Sprogis A, Henry DA.
The impact of specialists on prescribing by general practitioners.
Med J Aust 2001 15;175:(8):407-11

Robertson J, Treloar CJ, Sprogis A, Henry DA
The influence of specialists on prescribing by GPs. A qualitative study.
Aust Fam Physician 2003;32:(7):573-6.

Salunke AZ.
New inconvenient trend in advertising medicine.
J Indian Med Assoc 1994;92:(11):381

Sansom L.
The Australian National Medicinal Drug Policy.
J Qual Clin Pract 1999;19:(1):31-5;jsessionid=909680F0625E39ACB59C175C8B622321.d02t01

Schmidt HG, Norman GR, Boshuizen HP.
A cognitive perspective on medical expertise: theory and implication.
Acad Med 1990;65:(10):611-21;jsessionid=Q20ZpzJhktQPhgT1zJYgbyXTg90kPXkLl1s4J8xWn8lFZBjZVjf2!755119086!181195629!8091!-1?issn=1040-2446&volume=65&issue=10&spage=611

Shaughnessy AF, D'Amico F.
Long-term experience with a program to improve prescription-writing skills.
Fam Med 1994;26:(3):168-71

Page 205 of 206 pages ‹ First  < 203 204 205 206 > 


  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Click to Register

(read more)

Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts

If there is something you don't like, please tell us. If you like our work, please tell others. influence multinational corporations effectively, the efforts of governments will have to be complemented by others, notably the many voluntary organisations that have shown they can effectively represent society’s public-health interests…
A small group known as Healthy Skepticism; formerly the Medical Lobby for Appropriate Marketing) has consistently and insistently drawn the attention of producers to promotional malpractice, calling for (and often securing) correction. These organisations [Healthy Skepticism, Médecins Sans Frontières and Health Action International] are small, but they are capable; they bear malice towards no one, and they are inscrutably honest. If industry is indeed persuaded to face up to its social responsibilities in the coming years it may well be because of these associations and others like them.
- Dukes MN. Accountability of the pharmaceutical industry. Lancet. 2002 Nov 23; 360(9346)1682-4.